1-3 of 3
Bin Lin
Close
Sort by
Journal Articles

Gene Therapy of Transfusion-Dependent β-Thalassemia Patients with Quick Engraftment of Reinfused Hematopoietic Stem Cells: An Investigator-Initiated Trial of KL003

Jinqi Huang, Yuming Zhang, Liang Liang, Jiayuan Wu, Xiaoqian Li, Zhonglu Ye, Bin Lin, Jingzhi Ma, Lingling Su, Qing Ye, Jianan Sun, Zhengliang Wang, Baozhen Sun, Xiaodong Hu, Peng Lv, Jianjun Tao, Ying Dang, Depei Wu, Youren Tong, Haoquan Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4998.
https://doi.org/10.1182/blood-2023-188499
Published: 2023
Journal Articles

Long-Term Outcome of Gemcitabine, Vinorelbine, Liposomal-Doxorubicin (GVD) As Salvage Regimen for Patients with Previously Heavily Treated Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma

Hui-qiang Huang, MD, PhD, Bing Bai, Qingqing Cai, Xu-Bin Lin, MD, Xiao-Xiao Wang, Qi-Chun Cai
Journal: Blood
Blood (2011) 118 (21): 1609.
https://doi.org/10.1182/blood.V118.21.1609.1609
Published: 2011
Journal Articles

The Triterpenoid 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid and Its Derivatives Inhibit Mitochondrial Lon Protease Activity: A Potential Novel Pathway for the Induction of Lymphoma Cell Death.

Steven H. Bernstein, MD, Bin Lin, PhD, Shannon Hilchey, PhD, N. Villaluna, L. Chen, K. Madura, Kim Morse, Hollie Metcalf, Michael Andreeff, MD, PhD, Paul S Brookes, PhD, Carolyn K Suzuki, PhD
Journal: Blood
Blood (2009) 114 (22): 414.
https://doi.org/10.1182/blood.V114.22.414.414
Published: 2009